A total of 941 Private Equity/Venture Financing deals (pending and completed) were announced in the Healthcare of the Asia-Pacific region, in the last twelve months resulting in a total deal value of over $53,672.8 million. In the LTM period, April 2022 turned out to be the most prolific in terms of deal size, with a total deal value of $18,089.3 million, resulting in an average deal value of $384.9 million during that month. On the other hand, the month of March 2022 was the most prolific in terms of deal volume, recording a total of 101 deals, resulting in an average deal value of $33.0 million during that month.
Of the 941 deals, the deal secured between KKR & Co Inc and Ramsay Health Care Ltd, was the largest Private Equity/Venture Financing deal in the Asia-Pacific Healthcare sector, which was valued at $17,004.8 million and was completed on April 20, 2022. The second-largest deal was between CBC Group and Hugel Inc, while the third-largest deal was between FountainVest Partners and Beijing Zhendong Langdi Pharmaceutical Co Ltd. The CBC Group-Hugel Inc deal and the FountainVest Partners-Beijing Zhendong Langdi Pharmaceutical Co Ltd deal were valued at $1,500.0 million and $900.0 million, respectively. The fourth-largest deal was between 5Y Capital; AIHC Capital Management Limited; Alwin Capital; BioTrack Capital; Boyu Capital Consultancy Co. Ltd; CTS Capital Advisors LLC; Firstred Capital; Gaorong Capital; GL Ventures; HighLight Capital (China); Invesco Developing Markets Fund; Kaiser Permanente Ventures; Legend Capital Co Ltd; Lilly Asia ventures; Loyal Valley Capital; MSA Capital; Octagon Capital Group LLC; Oriental Spring; PICC Capital Equity Investment Co Ltd; Qiming Venture Partners; Temasek Holdings (Private) Ltd; Tiger Jade Capital LLP; Winfast Holding; Yingke PE; Youshan Capital; Yunfeng Capital-Suzhou Abogen Biosciences Co Ltd valued at $700.0 million, whereas the deal between BCPE Centur Investments , LP-Classys Inc. valued at $556.1 million was the fifth-largest deal.
Cumulatively, the top five deals amounted to $20,660.9 million and accounted for nearly 38.49% of the total deals (by value) announced during the last twelve months. The Asia-Pacific region accounted for 24.29% of the total Private Equity/Venture Financing deals done globally, and accounted for 1.45% of the total deal size on a global scale.
United States of America
United States of America
China
United States of America
United States of America
United States of America
Ireland
United States of America
Japan
United States of America
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer